A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 4, Pages 818-825
Publisher
Informa UK Limited
Online
2015-05-28
DOI
10.1080/21645515.2015.1011954
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly
- (2014) C. Raina MacIntyre et al. PLoS One
- Modeling of Cost Effectiveness of Pneumococcal Conjugate Vaccination Strategies in U.S. Older Adults
- (2013) Kenneth J. Smith et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model
- (2013) Roberto Pradas et al. BMC INFECTIOUS DISEASES
- Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults
- (2013) Kenneth J. Smith et al. VACCINE
- Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions
- (2013) Bo-Hyun Cho et al. VACCINE
- Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy
- (2013) Giorgio Liguori et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy
- (2013) Sara Boccalini et al. Human Vaccines & Immunotherapeutics
- Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease
- (2012) Mark T. Dransfield et al. CLINICAL INFECTIOUS DISEASES
- Editorial Commentary: Should 13-Valent Protein-Conjugate Pneumococcal Vaccine Be Used Routinely in Adults?
- (2012) D. M. Musher CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine
- (2012) Kenneth J. Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years
- (2012) Derek Weycker et al. VACCINE
- Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis
- (2012) M. H. Rozenbaum et al. BMJ-British Medical Journal
- A Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in Adults
- (2011) R. Lazarus et al. CLINICAL INFECTIOUS DISEASES
- Serotype replacement in disease after pneumococcal vaccination
- (2011) Daniel M Weinberger et al. LANCET
- Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands
- (2010) Mark H. Rozenbaum et al. CLINICAL THERAPEUTICS
- The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly
- (2010) Helen E. Baxendale et al. VACCINE
- Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55–70 Years of Age
- (2009) Karen M. Miernyk et al. CLINICAL INFECTIOUS DISEASES
- The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years
- (2009) David Goldblatt et al. CLINICAL INFECTIOUS DISEASES
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory
- (2008) Andrés de Roux et al. CLINICAL INFECTIOUS DISEASES
- Initial and Subsequent Response to Pneumococcal Polysaccharide and Protein‐Conjugate Vaccines Administered Sequentially to Adults Who Have Recovered from Pneumococcal Pneumonia
- (2008) Daniel M. Musher et al. JOURNAL OF INFECTIOUS DISEASES
- Immunological responses to pneumococcal vaccine in frail older people
- (2008) I. Ridda et al. VACCINE
- Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
- (2007) Matthew E. Falagas et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More